Literature DB >> 15125011

Accounting for center-of-mass target motion using convolution methods in Monte Carlo-based dose calculations of the lung.

Indrin J Chetty1, Mihaela Rosu, Daniel L McShan, Benedick A Fraass, James M Balter, Randall K Ten Haken.   

Abstract

We have applied convolution methods to account for some of the effects of respiratory induced motion in clinical treatment planning of the lung. The 3-D displacement of the GTV center-of-mass (COM) as determined from breath-hold exhale and inhale CT scans was used to approximate the breathing induced motion. The time-course of the GTV-COM was estimated using a probability distribution function (PDF) previously derived from diaphragmatic motion [Med. Phys. 26, 715-720 (1990)] but also used by others for treatment planning in the lung [Int. J. Radiat. Oncol., Biol., Phys. 53, 822-834 (2002); Med. Phys. 30, 1086-1095 (2003)]. We have implemented fluence and dose convolution methods within a Monte Carlo based dose calculation system with the intent of comparing these approaches for planning in the lung. All treatment plans in this study have been calculated with Monte Carlo using the breath-hold exhale CT data sets. An analysis of treatment plans for 3 patients showed substantial differences (hot and cold spots consistently greater than +/- 15%) between the motion convolved and static treatment plans. As fluence convolution accounts for the spatial variance of the dose distribution in the presence of tissue inhomogeneities, the doses were approximately 5% greater than those calculated with dose convolution in the vicinity of the lung. DVH differences between the static, fluence and dose convolved distributions for the CTV were relatively small, however, larger differences were observed for the PTV. An investigation of the effect of the breathing PDF asymmetry on the motion convolved dose distributions showed that reducing the asymmetry resulted in increased hot and cold spots in the motion convolved distributions relative to the static cases. In particular, changing from an asymmetric breathing function to one that is symmetric results in an increase in the hot/cold spots of +/- 15% relative to the static plan. This increase is not unexpected considering that the target spends relatively more time at inhale as the asymmetry decreases (note that the treatment plans were generated using the exhale CT scans).

Entities:  

Mesh:

Year:  2004        PMID: 15125011     DOI: 10.1118/1.1669083

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  5 in total

1.  Method for Fast CT/SPECT-Based 3D Monte Carlo Absorbed Dose Computations in Internal Emitter Therapy.

Authors:  S J Wilderman; Y K Dewaraja
Journal:  IEEE Trans Nucl Sci       Date:  2007-02-17       Impact factor: 1.679

2.  Computing proton dose to irregularly moving targets.

Authors:  Justin Phillips; Gueorgui Gueorguiev; James A Shackleford; Clemens Grassberger; Stephen Dowdell; Harald Paganetti; Gregory C Sharp
Journal:  Phys Med Biol       Date:  2014-07-16       Impact factor: 3.609

3.  Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: A review from NRG oncology.

Authors:  Edward D Brandner; Indrin J Chetty; Tawfik G Giaddui; Ying Xiao; M Saiful Huq
Journal:  Med Phys       Date:  2017-04-20       Impact factor: 4.071

4.  Incorporating system latency associated with real-time target tracking radiotherapy in the dose prediction step.

Authors:  Teboh Roland; Panayiotis Mavroidis; Chengyu Shi; Nikos Papanikolaou
Journal:  Phys Med Biol       Date:  2010-04-19       Impact factor: 3.609

5.  A study of quantitative indicators for slice sorting in cine-mode 4DCT.

Authors:  Changhwan Kim; Hojae Kim; Sung-Woo Kim; Youngmoon Goh; Min-Jae Park; Hojin Kim; Chiyoung Jeong; Byungchul Cho; Eun Kyung Choi; Sang-Wook Lee; Sang Min Yoon; Su Ssan Kim; Jin-Hong Park; Jinhong Jung; Si Yeol Song; Jungwon Kwak
Journal:  PLoS One       Date:  2022-08-26       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.